Peterson Timothy J, Feldman Greg, Harley Rebecca, Fresco David M, Graves Lesley, Holmes Avram, Bogdan Ryan, Papakostas George I, Bohn Laurie, Lury R Alana, Fava Maurizio, Segal Zindel V
Rhode Island Hospital Department of Psychiatry, Mood Disorders Program, Providence, RI 02903, USA.
J Consult Clin Psychol. 2007 Feb;75(1):145-53. doi: 10.1037/0022-006X.75.1.145.
The authors examined extreme response style in recurrently and chronically depressed patients, assessing its role in therapeutic outcome. During the acute phase, outpatients with major depressive disorder (N = 384) were treated with fluoxetine for 8 weeks. Remitted patients (n = 132) entered a continuation phase during which their fluoxetine dose increased and they were randomly assigned to treatment with or without cognitive-behavioral therapy (CBT). Results showed a predictive relationship between extreme response style and clinical outcome. Patients in the medication-only group showed a significant increase in the frequency of extreme responses, whereas patients receiving CBT showed no significant change. These results are consistent with recent findings suggesting that metacognitive factors may be as important as changes in thought content when treating depression.
作者研究了复发性和慢性抑郁症患者的极端反应方式,评估其在治疗结果中的作用。在急性期,患有重度抑郁症的门诊患者(N = 384)接受了8周的氟西汀治疗。缓解的患者(n = 132)进入维持期,在此期间他们的氟西汀剂量增加,并被随机分配接受或不接受认知行为疗法(CBT)治疗。结果显示极端反应方式与临床结果之间存在预测关系。仅接受药物治疗的组中极端反应的频率显著增加,而接受CBT治疗的患者则无显著变化。这些结果与最近的研究结果一致,表明在治疗抑郁症时,元认知因素可能与思维内容的变化同样重要。